Patent 7795496 was granted and assigned to Synageva BioPharma on September, 2010 by the United States Patent and Trademark Office.
The present invention provides for methods of producing transgenic avians which may include delivering a heterologous nucleic acid to oviduct tissue of an avian wherein the nucleic acid enters a cell of the oviduct tissue and is expressed.